Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 16 » PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Please verify you are not a robot.
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 16 » PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Please verify you are not a robot.